Drug Shortage Report for DIASTAT
| Report ID | 236858 |
| Drug Identification Number | 02238162 |
| Brand name | DIASTAT |
| Common or Proper name | DIASTAT |
| Company Name | BAUSCH HEALTH, CANADA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | DIAZEPAM |
| Strength(s) | 5MG |
| Dosage form(s) | GEL |
| Route of administration | RECTAL RECTAL |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 2PK |
| ATC code | N05BA |
| ATC description | ANXIOLYTICS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2024-09-03 |
| Estimated end date | 2024-10-07 |
| Actual end date | 2024-10-07 |
| Shortage status | Resolved |
| Updated date | 2024-10-10 |
| Company comments | Capacity Problem in Production |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2024-10-10 | French | Compare |
| v5 | 2024-10-10 | English | Compare |
| v4 | 2024-09-25 | French | Compare |
| v3 | 2024-09-25 | English | Compare |
| v2 | 2024-09-05 | French | Compare |
| v1 | 2024-09-05 | English | Compare |
Showing 1 to 6 of 6